California Bill On PBM Transparency Vetoed By Gov. Schwarzenegger
This article was originally published in The Pink Sheet Daily
Executive Summary
Measure “would have the unintended consequence of increasing drug costs” for insurers and Medi-Cal “without providing any real consumer benefit,” Schwarzenegger says. California becomes the tenth state to rebuff legislation that would impose certain disclosure requirements on PBMs, PCMA says.